WO2009120022A3 - 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 - Google Patents
면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 Download PDFInfo
- Publication number
- WO2009120022A3 WO2009120022A3 PCT/KR2009/001536 KR2009001536W WO2009120022A3 WO 2009120022 A3 WO2009120022 A3 WO 2009120022A3 KR 2009001536 W KR2009001536 W KR 2009001536W WO 2009120022 A3 WO2009120022 A3 WO 2009120022A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hpv
- immunopeptide
- prophylaxis
- treatment
- composition
- Prior art date
Links
- 238000011321 prophylaxis Methods 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
본 발명은 면역성 펩타이드 및 그 펩타이드를 포함하는 HPV 관련 질환 예방 또는 치료용 조성물에 관한 것으로 더욱 상세하게는 HPV type 16의 E7 단백질 유래 E7 면역성 펩타이드 및 그 펩타이드를 포함하는 HPV 관련 질환 예방 또는 치료용 조성물에 관한 것이다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080029256A KR20090103571A (ko) | 2008-03-28 | 2008-03-28 | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련질환 예방 또는 치료용 조성물 |
KR10-2008-0029256 | 2008-03-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009120022A2 WO2009120022A2 (ko) | 2009-10-01 |
WO2009120022A3 true WO2009120022A3 (ko) | 2009-12-23 |
Family
ID=41114459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/001536 WO2009120022A2 (ko) | 2008-03-28 | 2009-03-26 | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20090103571A (ko) |
WO (1) | WO2009120022A2 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090125629A (ko) * | 2008-06-02 | 2009-12-07 | 바이오코아 주식회사 | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련질환 예방 또는 치료용 조성물 |
WO2016006873A1 (ko) * | 2014-07-09 | 2016-01-14 | 연세대학교 산학협력단 | 인유두종바이러스 펩타이드의 자궁경부암 진단 및 치료 용도 |
CA3037086A1 (en) | 2016-10-03 | 2018-04-12 | Juno Therapeutics, Inc. | Hpv-specific binding molecules |
US11952408B2 (en) | 2017-10-03 | 2024-04-09 | Juno Therapeutics, Inc. | HPV-specific binding molecules |
WO2019195486A1 (en) | 2018-04-05 | 2019-10-10 | Juno Therapeutics, Inc. | T cell receptors and engineered cells expressing same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040170644A1 (en) * | 2001-05-04 | 2004-09-02 | Bernard Mailere | Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
US7201908B2 (en) * | 2001-03-23 | 2007-04-10 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Modified HPV E6 and E7 genes and proteins useful for vaccination |
-
2008
- 2008-03-28 KR KR1020080029256A patent/KR20090103571A/ko not_active Application Discontinuation
-
2009
- 2009-03-26 WO PCT/KR2009/001536 patent/WO2009120022A2/ko active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
US7201908B2 (en) * | 2001-03-23 | 2007-04-10 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Modified HPV E6 and E7 genes and proteins useful for vaccination |
US20040170644A1 (en) * | 2001-05-04 | 2004-09-02 | Bernard Mailere | Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
Non-Patent Citations (3)
Title |
---|
CHENHONG ZHANG.: "An Improved Fully Connected Hidden Markov Model for Rational", VACCINE DESIGN., 2005, UNIVERSITY OF SASKATCHEWAN (THESIS) * |
SATOKO MORISHIMA ET AL.: "Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: The combined effects of bortezomib and interferon- y on the presentation of a cryptic epitope.", INTERNATIONAL JOURNAL OF CANCER., vol. 120, no. 3, 2006, pages 594 - 604 * |
YI-FANG CHEN ET AL.: "Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 Mice.", JOURNAL OF VIROLOGY., vol. 78, no. 3, 2004, pages 1333 - 1343 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009120022A2 (ko) | 2009-10-01 |
KR20090103571A (ko) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009059325A3 (en) | Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2009126688A8 (en) | Novel compositions and methods for the treatment of immune related diseases | |
MY161495A (en) | Virus like particle compositions and methods of use | |
WO2009155001A3 (en) | Wnt protein signalling inhibitors | |
EA025278B9 (ru) | Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов | |
CN102036649A8 (zh) | 精氨酸盐及其治疗口腔疾病的用途 | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
IN2012DN00624A (ko) | ||
WO2008115281A3 (en) | Compounds for treating viral infections | |
WO2009089635A9 (en) | Treating neurodegenerative diseases with progranulin (pgrn) | |
WO2007125105A3 (en) | Benzamide glucokinase activators | |
WO2010055082A3 (en) | New crystal form of sunitinib malate | |
WO2011017132A3 (en) | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration | |
WO2008149353A3 (en) | Telomerase activating compounds and methods of use thereof | |
WO2010147830A3 (en) | Aminothiazole modulators of beta-3-adrenoreceptor | |
WO2009002159A3 (en) | Intradermal hpv peptide vaccination | |
ZA201101517B (en) | Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof | |
WO2009120022A3 (ko) | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 | |
WO2009136997A3 (en) | Inhibitors of human cathepsin l, cathepsin b, and cathepsin s | |
WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
WO2009148229A3 (ko) | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 | |
WO2007103584A3 (en) | Polyamides for treating human papilloma virus | |
WO2009148230A3 (ko) | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09725252 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09725252 Country of ref document: EP Kind code of ref document: A2 |